Adverse drug reaction profile at psychiatry out-patient department of a tertiary referral centre in Central India

Bhupendra Solanke, Mohini S. Mahatme, Ganesh Dakhale, Sachin Hiware, Meena Shrivastava, Pravin Waradkar

Abstract


Modern lifestyle and unfulfilled desires leads to very common diseases of today like anxiety, depression and schizophrenia. Therefore, last one and half decade there has been an exponential rise in the use of psychotropic medication. Antipsychotic polypharmacy is being practiced with increasing frequency. Polypharmacy is one of the leading cause of adverse drug reactions (ADRs) in psychiatric patients. In India, pharmacovigilance activity is still in initial stages and there are only few reports available on incidence of ADRs due to psychopharmacological agents (PPAs). Also, India rates below 1% in terms of ADR reporting against the world’s rate of 5%. Very few studies have described patient characteristics and treatment patterns associated with long-term use of the drugs. This prompted us to do evaluation of adverse drug reactions of PPAs in tertiary referral centre for a longer duration. This study was designed to prospectively monitor and analyze the pattern of occurrence of ADRs to PPAs in OPD of our tertiary care hospital. Our further aim was to make causality and severity analysis of psychopharmacological drug reactions.

Keywords


Psychiatry, Polypharmacy, Pharmacovigilance

Full Text:

PDF

References


Sengupta G, Bhowmick S, Hazra A, Datta A, Rahaman M. Adverse drug reaction monitoring in psychiatry out-patient department of an Indian teaching hospital. Indian J Pharmacol 2011;43:36-9.

Rani FA, Byrne PJ, Murray ML, Carter P, Wong IC. Paediatric atypical antipsychotic monitoring safety (PAMS) study: Pilot study in children and adolescents in secondary and tertiary care settings. Drug Saf 2009;32:325-33.

Amit D, Rataboli P. Adverse drug reaction notification drop box: an easy way to report ADRs. Br J Clin Pharmacol 2008;66:723-4.

The use of the WHO- UMC system for the standardized case causality assessment [monograph on the internet]. Uppsala: the Uppsala monitoring centre; 2005. Available at http://www.who-umc.org/graphics/4409.pdf. Accessed 20 February 2013.

Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm 1992;49:2229-32.